| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 157, Issue 1 29-38, Copyright © 1996 by American Association of Immunologists
ARTICLES |
I Kariv, A Truneh and RW Sweet
Department of Molecular Immunology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406, USA.
CD28 and CTLA-4 are homologue members of the Ig superfamily of molecules, containing a single V-like domain, transmembrane, and cytoplasmic regions. Both receptors associate with the counter- receptors CD80 and CD86, but the avidity of interaction for CD28 is about 20-fold lower than for CTLA-4. The interaction between CD28 and its cognate receptors provides a costimulatory signal for optimal T cell activation. Our previous mutational analysis of CD28 defined the highly conserved "MYPPPY" motif in the CDR3-region of the V-like domain as a key site of common and selective recognition. We have extended our analysis to cover all residues in the membrane distal loops of the V region, examining their effect on association with CD80/CD86 in cell adhesion and novel protein-based binding assays, and determining correlation between binding and functional response. Conservative F substitutions at either Y residue in the MYPPPY motif selectively reduced binding to CD86, but mutation of the three amino acids immediately C-terminal to Y 104 equivalently reduced binding to both co- receptors. The conservative F substitution of Y 26 in the CDR1-like region also reduced binding to CD80 and CD86. Other substitutions in the CDR1 loop and mutations spanning the CDR2 and DE loops had no effect. We conclude that the CDR1 and CDR3 regions contribute to a common binding site for CD80/CD86, and that the CDR3 region also carries determinants for selective recognition of these counter- receptors within the MYPPPY motif. Furthermore, for CD28, the strength of functional response, as measured by IL-2 production, directly correlates with binding avidity.
This article has been cited by other articles:
|
|
 |
|
  C. M. Kowolik, M. S. Topp, S. Gonzalez, T. Pfeiffer, S. Olivares, N. Gonzalez, D. D. Smith, S. J. Forman, M. C. Jensen, and L. J.N. Cooper CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances In vivo Persistence and Antitumor Efficacy of Adoptively Transferred T Cells. Cancer Res., November 15, 2006; 66(22): 10995 - 11004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Lewis, M. Merched-Sauvage, J. J. Goronzy, C. M. Weyand, and A. N. Vallejo Tumor Necrosis Factor-{alpha} and CD80 Modulate CD28 Expression through a Similar Mechanism of T-cell Receptor-independent Inhibition of Transcription J. Biol. Chem., July 9, 2004; 279(28): 29130 - 29138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sorensen, M. Kussmann, A. Rosen, K. L. Bennett, D. d. G. Thrige, K. Uvebrant, B. Walse, P. Roepstorff, and P. Bjork Identification of Protein-Protein Interfaces Implicated in CD80-CD28 Costimulatory Signaling J. Immunol., June 1, 2004; 172(11): 6803 - 6809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, J.-C. D. Schwartz, S. C. Almo, and S. G. Nathenson Crystal structure of the receptor-binding domain of human B7-2: Insights into organization and signaling PNAS, March 4, 2003; 100(5): 2586 - 2591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Giguere, J.-S. Paquette, S. Bounou, R. Cantin, and M. J. Tremblay New Insights into the Functionality of a Virion-Anchored Host Cell Membrane Protein: CD28 Versus HIV Type 1 J. Immunol., September 1, 2002; 169(5): 2762 - 2771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q.-B. Yang, M. Martin, S. M. Michalek, and J. Katz Mechanisms of Monophosphoryl Lipid A Augmentation of Host Responses to Recombinant HagB from Porphyromonas gingivalis Infect. Immun., July 1, 2002; 70(7): 3557 - 3565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liu, K. Geboes, P. Hellings, P. Maerten, H. Heremans, P. Vandenberghe, L. Boon, P. van Kooten, P. Rutgeerts, and J. L. Ceuppens B7 Interactions with CD28 and CTLA-4 Control Tolerance or Induction of Mucosal Inflammation in Chronic Experimental Colitis J. Immunol., August 1, 2001; 167(3): 1830 - 1838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Martin-Fontecha, M. Moro, M. C. Crosti, F. Veglia, G. Casorati, and P. Dellabona Vaccination with Mouse Mammary Adenocarcinoma Cells Coexpressing B7-1 (CD80) and B7-2 (CD86) Discloses the Dominant Effect of B7-1 in the Induction of Antitumor Immunity J. Immunol., January 15, 2000; 164(2): 698 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Vallejo, J. C. Brandes, C. M. Weyand, and J. J. Goronzy Modulation of CD28 Expression: Distinct Regulatory Pathways During Activation and Replicative Senescence J. Immunol., June 1, 1999; 162(11): 6572 - 6579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Olsson, K. Riebeck, M. Dohlsten, and E. Michaelsson CTLA-4 Ligation Suppresses CD28-induced NF-kappa B and AP-1 Activity in Mouse T Cell Blasts J. Biol. Chem., May 14, 1999; 274(20): 14400 - 14405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Slavik, J. E. Hutchcroft, and B. E. Bierer CD80 and CD86 Are Not Equivalent in Their Ability to Induce the Tyrosine Phosphorylation of CD28 J. Biol. Chem., January 29, 1999; 274(5): 3116 - 3124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fukumoto, N. Torigoe, Y. Ito, Y. Kajiwara, and K. Sugimura T Cell Proliferation-Augmenting Activities of the Gene 3 Protein Derived from a Phage Library Clone with CD80-Binding Activity J. Immunol., December 15, 1998; 161(12): 6622 - 6628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Fields, R. J. Finch, G. S. Gray, R. Zollner, J. L. Thomas, K. Sturmhoefel, K. Lee, S. Wolf, T. F. Gajewski, and F. W. Fitch B7.1 Is a Quantitatively Stronger Costimulus Than B7.2 in the Activation of Naive CD8+ TCR-Transgenic T Cells J. Immunol., November 15, 1998; 161(10): 5268 - 5275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Cilio, M. R. Daws, A. Malashicheva, C. L. Sentman, and D. Holmberg Cytotoxic T Lymphocyte Antigen 4 Is Induced in the Thymus upon In Vivo Activation and Its Blockade Prevents Anti-CD3-mediated Depletion of Thymocytes J. Exp. Med., October 5, 1998; 188(7): 1239 - 1246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Jirapongsananuruk, M. F. Hofer, A. E. Trumble, D. A. Norris, and D. Y. M. Leung Enhanced Expression of B7.2 (CD86) in Patients with Atopic Dermatitis: A Potential Role in the Modulation of IgE Synthesis J. Immunol., May 1, 1998; 160(9): 4622 - 4627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tsuyuki, J. Tsuyuki, K. Einsle, M. Kopf, and A. J. Coyle Costimulation through B7-2 (CD86) Is Required for the Induction of a Lung Mucosal T Helper Cell 2 (TH2) Immune Response and Altered Airway Responsiveness J. Exp. Med., May 5, 1997; 185(9): 1671 - 1680. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
